Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke
NCT ID: NCT02114736
Last Updated: 2014-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
20 participants
INTERVENTIONAL
2014-03-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to compare the benefit of the rectus femoris tenotomy in comparison with botulinum toxin A injections according to the 3 domains of the International Classification of Functioning Disability and Health of the World Health Organisation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stroke's Gait Pattern Modifications of Induced by Repeated BTI
NCT01973023
Effect of Repeated Botulinum Toxin Injection on Gait Pattern in Stroke Patients
NCT02699775
Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients
NCT02917850
Walking Therapy In Hemiparetic Stroke Patients Using Robotic-Assisted Treadmill Training
NCT00075283
Stimulation Combined With Powered Motorized Orthoses for Walking After Stroke
NCT04116671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Stroke is the third cause of death and the leading cause of handicap among industrialized countries. Spasticity and co-contraction of the rectus femoris muscle following stroke is responsible for a lack of knee flexion in the swing phase of gait named stiff knee gait.
The rectus femoris spasticity is usually treated by oral medications, physical therapy and botulinum toxin A injections (1,2). As botulinum toxin A has a transient effect, injections must be repeated supporting to promote a permanent surgical treatment such as the rectus femoris tenotomy (3). However, no study has evaluate neither compare the effect of the rectus femoris tenotomy on gait and on the 3 domains of the International Classification of Functioning Disability and Health .
OBJECTIVE
To compare the effect of the rectus femoris tenotomy and of the botulinum toxin A injections for stiff knee gait after stroke according to the 3 domains of the International Classification of Functioning Disability and Health
METHODS
The investigators will recruited 20 chronic stroke patients presenting with stiff knee gait. The patients will be randomly assigned to a surgical group treated by rectus femoris tenotomy (10 patients) and to a medical group treated by rectus femoris botulinum toxin A injections.
Patients will be assessed before treatment, 2 months and 6 months after treatment by an assessor blinded therapist among the 3 domains of the International Classification of Functioning Disability and Health
PERSPECTIVE
The investigator hope to demonstrate the effectiveness of the rectus femoris tenotomy as a treatment of stiff knee gait after stroke
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rectus femoris tenotomy
Surgical release of the proximal tendon of the rectus femoris
Tenotomy of the proximal rectus femoris tendon
Surgical release of the proximal tendon of the rectus femoris
Botulinum toxin in the rectus femoris muscle
Botulinum toxin (200U Botox) injection in the rectus femoris muscle
Botulinum Toxin injection in the rectus femoris muscle
Injections of 200U of Botox in the rectus femoris muscle with a 2ml/100U dilution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tenotomy of the proximal rectus femoris tendon
Surgical release of the proximal tendon of the rectus femoris
Botulinum Toxin injection in the rectus femoris muscle
Injections of 200U of Botox in the rectus femoris muscle with a 2ml/100U dilution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stiff knee gait
* rectus femoris spasticity (\> Ashworth 2)
* transient improvement with previous botulinum toxine A injection in the rectus femoris
* stiff knee gait improved after rectus femoris diagnostic motor nere block
* able to walk on treadmill
Exclusion Criteria
* botulinum toxin A injections in the rectus femoris \< 6 months
* previous surgery for stiff knee gait
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Mont-Godinne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deltombe Thierry
Professeur Clinique
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thierry Deltombe, M.D.
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Mont-Godinne, Université Catholique de Louvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Mont-Godinne
Yvoir, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Stoquart GG, Detrembleur C, Palumbo S, Deltombe T, Lejeune TM. Effect of botulinum toxin injection in the rectus femoris on stiff-knee gait in people with stroke: a prospective observational study. Arch Phys Med Rehabil. 2008 Jan;89(1):56-61. doi: 10.1016/j.apmr.2007.08.131.
Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke. 2008 Oct;39(10):2803-8. doi: 10.1161/STROKEAHA.108.516153. Epub 2008 Jul 17.
Namdari S, Pill SG, Makani A, Keenan MA. Rectus femoris to gracilis muscle transfer with fractional lengthening of the vastus muscles: a treatment for adults with stiff knee gait. Phys Ther. 2010 Feb;90(2):261-8. doi: 10.2522/ptj.20090151. Epub 2009 Dec 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MG-SKG-57/2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.